Corcept Therapeutics Inc (CORT)
ROA
Obliczenia
|
2023 (31 gru 2023) |
2022 (31 gru 2022) |
2021 (31 gru 2021) |
2020 (31 gru 2020) |
2019 (31 gru 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | 106 140 | 101 418 | 112 512 | 106 011 | 94 181 |
| Aktywa razem | w tys. USD | 621 517 | 583 430 | 423 756 | 571 731 | 412 312 |
| ROA | 17,08% | 17,38% | 26,55% | 18,54% | 22,84% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $106 140K ÷ $621 517K
= 17,08%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Corcept Therapeutics Inc
CORT
17,08%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Prestige Consumer Healthcare Inc
PBH
-2,45%
Schrodinger Inc
SDGR
5,07%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%